cellular process (GO:0009987) | 0.26 | 13 | WT1, ARHGDIA, NUP93, PLCE1, PTPRO, NUP107, NUP205, EMP2, LAMB2, OPA1, NPHS2, NPHS1, DGKE |
single-organism cellular process (GO:0044763) | 0.65 | 13 | WT1, ARHGDIA, NUP93, PTPRO, PLCE1, NUP107, NUP205, EMP2, LAMB2, OPA1, NPHS2, NPHS1, DGKE |
single-organism process (GO:0044699) | 0.48 | 13 | WT1, ARHGDIA, NUP93, PTPRO, PLCE1, NUP107, NUP205, EMP2, LAMB2, OPA1, NPHS2, NPHS1, DGKE |
cellular component organization (GO:0016043) | 1.24 | 11 | WT1, NUP93, PLCE1, PTPRO, NUP107, NUP205, EMP2, LAMB2, OPA1, NPHS2, NPHS1 |
biological regulation (GO:0065007) | 0.39 | 11 | WT1, ARHGDIA, NUP93, PLCE1, PTPRO, NUP107, NUP205, EMP2, OPA1, NPHS1, DGKE |
regulation of biological process (GO:0050789) | 0.45 | 11 | WT1, ARHGDIA, NUP93, PTPRO, PLCE1, NUP107, NUP205, EMP2, OPA1, NPHS1, DGKE |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 11 | WT1, NUP93, PLCE1, PTPRO, NUP107, NUP205, EMP2, LAMB2, OPA1, NPHS2, NPHS1 |
regulation of cellular process (GO:0050794) | 0.5 | 11 | WT1, ARHGDIA, NUP93, PTPRO, PLCE1, NUP107, NUP205, EMP2, OPA1, NPHS1, DGKE |
organic substance metabolic process (GO:0071704) | 0.63 | 8 | WT1, NUP93, PTPRO, PLCE1, NUP107, NUP205, NPHS1, DGKE |
regulation of response to stimulus (GO:0048583) | 1.54 | 8 | ARHGDIA, NUP93, PTPRO, PLCE1, NUP107, NUP205, EMP2, OPA1 |
cellular metabolic process (GO:0044237) | 0.69 | 8 | WT1, NUP93, PTPRO, PLCE1, NUP107, NUP205, NPHS1, DGKE |
metabolic process (GO:0008152) | 0.58 | 8 | WT1, NUP93, PTPRO, PLCE1, NUP107, NUP205, NPHS1, DGKE |
primary metabolic process (GO:0044238) | 0.69 | 8 | WT1, NUP93, PTPRO, PLCE1, NUP107, NUP205, NPHS1, DGKE |
developmental process (GO:0032502) | 1.36 | 7 | WT1, PTPRO, PLCE1, LAMB2, OPA1, NPHS2, NPHS1 |
multicellular organismal process (GO:0032501) | 1.45 | 7 | WT1, PTPRO, EMP2, LAMB2, OPA1, NPHS2, NPHS1 |
single-organism developmental process (GO:0044767) | 1.49 | 7 | WT1, PTPRO, PLCE1, LAMB2, OPA1, NPHS2, NPHS1 |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 7 | WT1, ARHGDIA, PLCE1, PTPRO, EMP2, OPA1, NPHS1 |
negative regulation of biological process (GO:0048519) | 1.33 | 7 | WT1, ARHGDIA, NUP93, PTPRO, NUP107, NUP205, OPA1 |
regulation of localization (GO:0032879) | 1.94 | 7 | ARHGDIA, NUP93, PTPRO, NUP107, NUP205, EMP2, NPHS1 |
organelle organization (GO:0006996) | 2.02 | 6 | NUP93, PLCE1, NUP107, NUP205, OPA1, NPHS2 |
organic substance biosynthetic process (GO:1901576) | 1.34 | 6 | WT1, NUP93, PLCE1, NUP107, NUP205, DGKE |
macromolecule metabolic process (GO:0043170) | 0.83 | 6 | WT1, NUP93, PTPRO, NUP107, NUP205, NPHS1 |
regulation of metabolic process (GO:0019222) | 1.02 | 6 | WT1, NUP93, PLCE1, NUP107, NUP205, EMP2 |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 6 | WT1, NUP93, PTPRO, NUP107, NUP205, NPHS1 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 6 | WT1, NUP93, PLCE1, NUP107, NUP205, EMP2 |
cellular developmental process (GO:0048869) | 1.82 | 6 | WT1, PTPRO, LAMB2, OPA1, NPHS2, NPHS1 |
anatomical structure development (GO:0048856) | 1.58 | 6 | WT1, PTPRO, PLCE1, LAMB2, NPHS2, NPHS1 |
regulation of cellular component organization (GO:0051128) | 2.01 | 6 | WT1, ARHGDIA, PTPRO, PLCE1, OPA1, NPHS1 |
cellular biosynthetic process (GO:0044249) | 1.37 | 6 | WT1, NUP93, PLCE1, NUP107, NUP205, DGKE |
biosynthetic process (GO:0009058) | 1.32 | 6 | WT1, NUP93, PLCE1, NUP107, NUP205, DGKE |
positive regulation of biological process (GO:0048518) | 1.2 | 6 | WT1, ARHGDIA, PLCE1, EMP2, OPA1, NPHS1 |
system process (GO:0003008) | 2.3 | 6 | PTPRO, EMP2, LAMB2, OPA1, NPHS2, NPHS1 |
localization (GO:0051179) | 1.4 | 6 | NUP93, NUP107, NUP205, EMP2, OPA1, NPHS1 |
positive regulation of cellular process (GO:0048522) | 1.3 | 6 | WT1, ARHGDIA, PLCE1, EMP2, OPA1, NPHS1 |
protein localization (GO:0008104) | 2.36 | 5 | NUP107, NPHS1, NUP93, EMP2, NUP205 |
regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 5 | WT1, EMP2, ARHGDIA, OPA1, PTPRO |
movement of cell or subcellular component (GO:0006928) | 2.61 | 5 | ARHGDIA, EMP2, LAMB2, OPA1, PTPRO |
membrane organization (GO:0061024) | 3.04 | 5 | NUP107, NUP93, EMP2, OPA1, NUP205 |
cellular component assembly (GO:0022607) | 2.14 | 5 | NUP107, NUP93, EMP2, PTPRO, NUP205 |
regulation of signaling (GO:0023051) | 1.72 | 5 | ARHGDIA, EMP2, OPA1, PLCE1, PTPRO |
regulation of cell communication (GO:0010646) | 1.73 | 5 | ARHGDIA, EMP2, OPA1, PLCE1, PTPRO |
cellular protein metabolic process (GO:0044267) | 1.63 | 5 | NUP107, NPHS1, NUP93, PTPRO, NUP205 |
regulation of signal transduction (GO:0009966) | 1.84 | 5 | ARHGDIA, EMP2, OPA1, PLCE1, PTPRO |
macromolecule localization (GO:0033036) | 2.34 | 5 | NUP93, NPHS1, NUP107, EMP2, NUP205 |
regulation of developmental process (GO:0050793) | 2.1 | 5 | WT1, ARHGDIA, OPA1, EMP2, PTPRO |
transport (GO:0006810) | 1.51 | 5 | NUP107, NUP93, OPA1, EMP2, NUP205 |
cellular protein modification process (GO:0006464) | 1.79 | 5 | NUP107, NPHS1, NUP93, PTPRO, NUP205 |
macromolecule modification (GO:0043412) | 1.73 | 5 | NUP107, NPHS1, NUP93, PTPRO, NUP205 |
protein modification process (GO:0036211) | 1.79 | 5 | NUP107, NPHS1, NUP93, PTPRO, NUP205 |
single-organism membrane organization (GO:0044802) | 3.19 | 5 | NUP107, NUP93, EMP2, OPA1, NUP205 |
establishment of localization in cell (GO:0051649) | 2.47 | 5 | NUP93, OPA1, NUP107, EMP2, NUP205 |
establishment of localization (GO:0051234) | 1.48 | 5 | NUP107, NUP93, OPA1, EMP2, NUP205 |
single-organism localization (GO:1902578) | 2.09 | 5 | NUP93, OPA1, NUP107, EMP2, NUP205 |
cellular localization (GO:0051641) | 2.32 | 5 | NUP107, NUP93, OPA1, EMP2, NUP205 |
intracellular transport (GO:0046907) | 2.67 | 5 | NUP107, OPA1, NUP93, EMP2, NUP205 |
protein metabolic process (GO:0019538) | 1.45 | 5 | NUP107, NPHS1, NUP93, PTPRO, NUP205 |
response to stimulus (GO:0050896) | 1.22 | 5 | WT1, ARHGDIA, NPHS1, OPA1, EMP2 |
regulation of multicellular organismal development (GO:2000026) | 2.31 | 5 | WT1, EMP2, ARHGDIA, OPA1, PTPRO |
single-organism cellular localization (GO:1902580) | 3.16 | 5 | NUP93, OPA1, NUP107, EMP2, NUP205 |
negative regulation of metabolic process (GO:0009892) | 1.93 | 4 | WT1, NUP93, NUP205, NUP107 |
regulation of primary metabolic process (GO:0080090) | 1.08 | 4 | WT1, NUP107, EMP2, PLCE1 |
regulation of transport (GO:0051049) | 2.24 | 4 | NUP107, NPHS1, NUP93, NUP205 |
cell development (GO:0048468) | 3.28 | 4 | WT1, NPHS1, NPHS2, LAMB2 |
nucleic acid metabolic process (GO:0090304) | 1.46 | 4 | WT1, NUP93, NUP205, NUP107 |
negative regulation of gene expression (GO:0010629) | 2.48 | 4 | WT1, NUP93, NUP205, NUP107 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 4 | WT1, NUP93, NUP205, NUP107 |
signal transduction (GO:0007165) | 1.28 | 4 | ARHGDIA, NPHS1, DGKE, PLCE1 |
regulation of cell differentiation (GO:0045595) | 2.42 | 4 | ARHGDIA, OPA1, EMP2, PTPRO |
intracellular signal transduction (GO:0035556) | 2.39 | 4 | ARHGDIA, NPHS1, DGKE, PLCE1 |
organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 4 | WT1, NUP93, NUP205, NUP107 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 4 | WT1, NUP93, NUP205, NUP107 |
RNA biosynthetic process (GO:0032774) | 1.84 | 4 | WT1, NUP93, NUP205, NUP107 |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 4 | WT1, NUP93, NUP205, NUP107 |
cellular response to stimulus (GO:0051716) | 1.97 | 4 | WT1, ARHGDIA, NPHS1, OPA1 |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 4 | WT1, NUP93, NUP205, NUP107 |
regulation of system process (GO:0044057) | 3.53 | 4 | PLCE1, NPHS1, EMP2, PTPRO |
regulation of gene expression (GO:0010468) | 1.37 | 4 | WT1, NUP93, NUP205, NUP107 |
heterocycle biosynthetic process (GO:0018130) | 1.7 | 4 | WT1, NUP93, NUP205, NUP107 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 4 | WT1, NUP107, PLCE1, EMP2 |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 4 | WT1, NUP93, NUP205, NUP107 |
single-organism transport (GO:0044765) | 2.18 | 4 | NUP107, NUP93, OPA1, NUP205 |
macromolecule biosynthetic process (GO:0009059) | 1.61 | 4 | WT1, NUP93, NUP205, NUP107 |
aromatic compound biosynthetic process (GO:0019438) | 1.7 | 4 | WT1, NUP93, NUP205, NUP107 |
nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 4 | WT1, NUP93, NUP205, NUP107 |
heterocycle metabolic process (GO:0046483) | 1.31 | 4 | WT1, NUP93, NUP205, NUP107 |
RNA metabolic process (GO:0016070) | 1.59 | 4 | WT1, NUP93, NUP205, NUP107 |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 4 | WT1, NUP93, NUP205, NUP107 |
regulation of response to stress (GO:0080134) | 2.53 | 4 | NUP107, NUP93, NUP205, OPA1 |
regulation of cellular response to stress (GO:0080135) | 3.4 | 4 | NUP107, NUP93, OPA1, NUP205 |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 4 | WT1, NUP93, NUP205, NUP107 |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 4 | DGKE, NPHS1, PLCE1, PTPRO |
phosphorus metabolic process (GO:0006793) | 2.15 | 4 | DGKE, NPHS1, PLCE1, PTPRO |
single-organism intracellular transport (GO:1902582) | 3.59 | 4 | NUP107, NUP93, NUP205, OPA1 |
negative regulation of cellular process (GO:0048523) | 1.41 | 4 | WT1, ARHGDIA, OPA1, PTPRO |
nuclear transport (GO:0051169) | 4.2 | 3 | NUP107, NUP93, NUP205 |
nuclear export (GO:0051168) | 4.74 | 3 | NUP107, NUP93, NUP205 |
regulation of cell projection organization (GO:0031344) | 3.38 | 3 | ARHGDIA, OPA1, PTPRO |
single-organism metabolic process (GO:0044710) | 1.63 | 3 | NPHS1, PLCE1, DGKE |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 3 | WT1, PLCE1, EMP2 |
cellular macromolecule localization (GO:0070727) | 3.1 | 3 | NUP93, NUP107, EMP2 |
protein modification by small protein conjugation or removal (GO:0070647) | 2.95 | 3 | NUP107, NUP93, NUP205 |
peptidyl-amino acid modification (GO:0018193) | 2.98 | 3 | NUP107, NUP93, NUP205 |
intracellular transport of virus (GO:0075733) | 5.57 | 3 | NUP107, NUP93, NUP205 |
interspecies interaction between organisms (GO:0044419) | 3.08 | 3 | NUP107, NUP93, NUP205 |
protein modification by small protein conjugation (GO:0032446) | 3.1 | 3 | NUP107, NUP93, NUP205 |
gene silencing (GO:0016458) | 4.6 | 3 | NUP107, NUP93, NUP205 |
animal organ development (GO:0048513) | 2.53 | 3 | WT1, NPHS1, PLCE1 |
positive regulation of molecular function (GO:0044093) | 2.23 | 3 | ARHGDIA, EMP2, PLCE1 |
epithelial cell development (GO:0002064) | 4.92 | 3 | NPHS1, NPHS2, LAMB2 |
glomerular basement membrane development (GO:0032836) | 7.43 | 3 | WT1, NPHS1, LAMB2 |
negative regulation of cell death (GO:0060548) | 2.95 | 3 | WT1, ARHGDIA, OPA1 |
glomerulus development (GO:0032835) | 7.33 | 3 | WT1, PLCE1, PTPRO |
nuclear pore complex assembly (GO:0051292) | 7.33 | 3 | NUP107, NUP93, NUP205 |
establishment of protein localization (GO:0045184) | 2.53 | 3 | NUP107, NUP93, NUP205 |
regulation of neuron projection development (GO:0010975) | 3.69 | 3 | ARHGDIA, OPA1, PTPRO |
mitotic nuclear envelope disassembly (GO:0007077) | 5.94 | 3 | NUP107, NUP93, NUP205 |
multi-organism process (GO:0051704) | 2.65 | 3 | NUP107, NUP93, NUP205 |
peptidyl-lysine modification (GO:0018205) | 3.98 | 3 | NUP107, NUP93, NUP205 |
extracellular matrix organization (GO:0030198) | 4.01 | 3 | WT1, NPHS1, LAMB2 |
positive regulation of metabolic process (GO:0009893) | 1.74 | 3 | WT1, PLCE1, EMP2 |
viral transcription (GO:0019083) | 4.98 | 3 | NUP107, NUP93, NUP205 |
mRNA transport (GO:0051028) | 4.74 | 3 | NUP107, NUP93, NUP205 |
regulation of apoptotic process (GO:0042981) | 2.5 | 3 | WT1, ARHGDIA, OPA1 |
cell morphogenesis (GO:0000902) | 4.35 | 3 | WT1, LAMB2, PTPRO |
macromolecular complex assembly (GO:0065003) | 2.55 | 3 | NUP107, NUP93, NUP205 |
regulation of molecular function (GO:0065009) | 1.78 | 3 | ARHGDIA, PLCE1, EMP2 |
regulation of biological quality (GO:0065008) | 1.68 | 3 | ARHGDIA, NPHS1, PLCE1 |
positive regulation of cellular component organization (GO:0051130) | 2.68 | 3 | ARHGDIA, NPHS1, OPA1 |
cellular protein localization (GO:0034613) | 3.11 | 3 | NUP93, NUP107, EMP2 |
regulation of neurogenesis (GO:0050767) | 3.21 | 3 | ARHGDIA, OPA1, PTPRO |
regulation of catalytic activity (GO:0050790) | 1.97 | 3 | ARHGDIA, PLCE1, EMP2 |
tRNA transport (GO:0051031) | 6.2 | 3 | NUP107, NUP93, NUP205 |
establishment of RNA localization (GO:0051236) | 4.58 | 3 | NUP107, NUP93, NUP205 |
regulation of intracellular signal transduction (GO:1902531) | 2.31 | 3 | ARHGDIA, PLCE1, OPA1 |
RNA transport (GO:0050658) | 4.59 | 3 | NUP107, NUP93, NUP205 |
organic substance transport (GO:0071702) | 2.15 | 3 | NUP107, NUP93, NUP205 |
nucleic acid transport (GO:0050657) | 4.59 | 3 | NUP107, NUP93, NUP205 |
regulation of nervous system development (GO:0051960) | 3.1 | 3 | ARHGDIA, OPA1, PTPRO |
transport of virus (GO:0046794) | 5.52 | 3 | NUP107, NUP93, NUP205 |
nucleobase-containing compound transport (GO:0015931) | 4.42 | 3 | NUP107, NUP93, NUP205 |
regulation of organelle organization (GO:0033043) | 2.72 | 3 | ARHGDIA, NPHS1, OPA1 |
regulation of cell adhesion (GO:0030155) | 3.27 | 3 | ARHGDIA, EMP2, PTPRO |
negative regulation of cellular component organization (GO:0051129) | 3.35 | 3 | ARHGDIA, OPA1, PTPRO |
glomerular epithelial cell development (GO:0072310) | 7.43 | 3 | NPHS1, NPHS2, LAMB2 |
anatomical structure morphogenesis (GO:0009653) | 2.53 | 3 | WT1, LAMB2, PTPRO |
positive regulation of catalytic activity (GO:0043085) | 2.4 | 3 | ARHGDIA, EMP2, PLCE1 |
glomerular visceral epithelial cell development (GO:0072015) | 7.53 | 3 | NPHS1, NPHS2, LAMB2 |
pore complex assembly (GO:0046931) | 6.96 | 3 | NUP107, NUP93, NUP205 |
regulation of neuron differentiation (GO:0045664) | 3.39 | 3 | ARHGDIA, OPA1, PTPRO |
positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 3 | WT1, ARHGDIA, OPA1 |
negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 3 | WT1, ARHGDIA, PTPRO |
regulation of protein metabolic process (GO:0051246) | 1.93 | 3 | WT1, PLCE1, EMP2 |
nuclear envelope disassembly (GO:0051081) | 5.88 | 3 | NUP107, NUP93, NUP205 |
regulation of cell development (GO:0060284) | 3.01 | 3 | ARHGDIA, OPA1, PTPRO |
macromolecular complex subunit organization (GO:0043933) | 2.14 | 3 | NUP107, NUP93, NUP205 |
biological adhesion (GO:0022610) | 2.81 | 3 | NPHS1, LAMB2, EMP2 |
regulation of cellular component movement (GO:0051270) | 3.08 | 3 | ARHGDIA, EMP2, PTPRO |
protein sumoylation (GO:0016925) | 4.98 | 3 | NUP107, NUP93, NUP205 |
negative regulation of developmental process (GO:0051093) | 3.17 | 3 | WT1, ARHGDIA, PTPRO |
membrane disassembly (GO:0030397) | 5.88 | 3 | NUP107, NUP93, NUP205 |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 3 | WT1, PLCE1, EMP2 |
positive regulation of developmental process (GO:0051094) | 2.77 | 3 | WT1, ARHGDIA, OPA1 |
regulation of cellular response to heat (GO:1900034) | 5.41 | 3 | NUP107, NUP93, NUP205 |
cell projection organization (GO:0030030) | 3.14 | 3 | LAMB2, EMP2, PTPRO |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 3 | WT1, EMP2, PLCE1 |
mitotic cell cycle process (GO:1903047) | 3.12 | 3 | NUP107, NUP93, NUP205 |
regulation of glucose transport (GO:0010827) | 5.12 | 3 | NUP107, NUP93, NUP205 |
cell cycle process (GO:0022402) | 2.75 | 3 | NUP107, NUP93, NUP205 |
protein transport (GO:0015031) | 2.62 | 3 | NUP107, NUP93, NUP205 |
cellular macromolecular complex assembly (GO:0034622) | 3.18 | 3 | NUP107, NUP93, NUP205 |
regulation of cell death (GO:0010941) | 2.43 | 3 | WT1, ARHGDIA, OPA1 |
protein complex subunit organization (GO:0071822) | 2.6 | 3 | NUP107, NUP93, NUP205 |
cellular component morphogenesis (GO:0032989) | 3.5 | 3 | WT1, LAMB2, PTPRO |
nitrogen compound transport (GO:0071705) | 3.54 | 3 | NUP107, NUP93, NUP205 |
tRNA export from nucleus (GO:0006409) | 6.26 | 3 | NUP107, NUP93, NUP205 |
regulation of programmed cell death (GO:0043067) | 2.49 | 3 | WT1, ARHGDIA, OPA1 |
negative regulation of apoptotic process (GO:0043066) | 3.04 | 3 | WT1, ARHGDIA, OPA1 |
extracellular structure organization (GO:0043062) | 4.0 | 3 | WT1, NPHS1, LAMB2 |
negative regulation of programmed cell death (GO:0043069) | 3.02 | 3 | WT1, ARHGDIA, OPA1 |
RNA export from nucleus (GO:0006405) | 5.01 | 3 | NUP107, NUP93, NUP205 |
mRNA export from nucleus (GO:0006406) | 5.11 | 3 | NUP107, NUP93, NUP205 |
protein complex assembly (GO:0006461) | 2.78 | 3 | NUP107, NUP93, NUP205 |
nucleocytoplasmic transport (GO:0006913) | 4.23 | 3 | NUP107, NUP93, NUP205 |
multi-organism transport (GO:0044766) | 5.51 | 3 | NUP107, NUP93, NUP205 |
multi-organism cellular process (GO:0044764) | 3.14 | 3 | NUP107, NUP93, NUP205 |
cellular component disassembly (GO:0022411) | 3.52 | 3 | NUP107, NUP93, NUP205 |
gene silencing by RNA (GO:0031047) | 5.07 | 3 | NUP107, NUP93, NUP205 |
cell adhesion (GO:0007155) | 2.82 | 3 | NPHS1, LAMB2, EMP2 |
cellular protein complex assembly (GO:0043623) | 3.9 | 3 | NUP107, NUP93, NUP205 |
multi-organism localization (GO:1902579) | 5.51 | 3 | NUP107, NUP93, NUP205 |
nucleus organization (GO:0006997) | 5.49 | 3 | NUP107, NUP93, NUP205 |
regulation of locomotion (GO:0040012) | 3.12 | 3 | ARHGDIA, EMP2, PTPRO |
nuclear envelope organization (GO:0006998) | 5.45 | 3 | NUP107, NUP93, NUP205 |
nuclear pore organization (GO:0006999) | 7.02 | 3 | NUP107, NUP93, NUP205 |
single-organism organelle organization (GO:1902589) | 2.68 | 3 | NPHS2, NUP93, OPA1 |
viral process (GO:0016032) | 3.15 | 3 | NUP107, NUP93, NUP205 |
multi-organism intracellular transport (GO:1902583) | 5.57 | 3 | NUP107, NUP93, NUP205 |
symbiosis, encompassing mutualism through parasitism (GO:0044403) | 3.15 | 3 | NUP107, NUP93, NUP205 |
(GO:1902581) | 5.57 | 3 | NUP107, NUP93, NUP205 |
regulation of phosphate metabolic process (GO:0019220) | 2.35 | 2 | EMP2, PLCE1 |
negative regulation of response to stimulus (GO:0048585) | 2.52 | 2 | OPA1, PTPRO |
positive regulation of response to stimulus (GO:0048584) | 2.18 | 2 | PLCE1, EMP2 |
activation of protein kinase activity (GO:0032147) | 4.08 | 2 | PLCE1, EMP2 |
negative regulation of cell adhesion (GO:0007162) | 4.33 | 2 | ARHGDIA, PTPRO |
renal system process (GO:0003014) | 5.17 | 2 | EMP2, PTPRO |
cell surface receptor signaling pathway (GO:0007166) | 2.09 | 2 | ARHGDIA, PLCE1 |
negative regulation of cell projection organization (GO:0031345) | 4.72 | 2 | ARHGDIA, PTPRO |
mitochondrion organization (GO:0007005) | 3.69 | 2 | NUP93, OPA1 |
positive regulation of cell projection organization (GO:0031346) | 3.99 | 2 | ARHGDIA, OPA1 |
muscle organ development (GO:0007517) | 4.98 | 2 | WT1, NPHS1 |
single-organism biosynthetic process (GO:0044711) | 2.8 | 2 | DGKE, PLCE1 |
negative regulation of signal transduction (GO:0009968) | 2.75 | 2 | OPA1, PTPRO |
positive regulation of signal transduction (GO:0009967) | 2.5 | 2 | PLCE1, EMP2 |
regulation of glomerular filtration (GO:0003093) | 7.33 | 2 | EMP2, PTPRO |
regulation of cytoskeleton organization (GO:0051493) | 3.72 | 2 | ARHGDIA, NPHS1 |
negative regulation of neuron differentiation (GO:0045665) | 4.45 | 2 | ARHGDIA, PTPRO |
positive regulation of neuron differentiation (GO:0045666) | 3.98 | 2 | ARHGDIA, OPA1 |
positive regulation of cell development (GO:0010720) | 3.57 | 2 | ARHGDIA, OPA1 |
epithelial cell differentiation (GO:0030855) | 3.98 | 2 | WT1, PTPRO |
regulation of cell proliferation (GO:0042127) | 2.41 | 2 | WT1, EMP2 |
regulation of small GTPase mediated signal transduction (GO:0051056) | 4.08 | 2 | ARHGDIA, PLCE1 |
regulation of protein kinase activity (GO:0045859) | 3.15 | 2 | EMP2, PLCE1 |
visual perception (GO:0007601) | 4.41 | 2 | LAMB2, OPA1 |
sensory perception (GO:0007600) | 2.93 | 2 | LAMB2, OPA1 |
negative regulation of neuron projection development (GO:0010977) | 4.88 | 2 | ARHGDIA, PTPRO |
positive regulation of neuron projection development (GO:0010976) | 4.26 | 2 | ARHGDIA, OPA1 |
regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 2 | WT1, NUP107 |
neuron projection guidance (GO:0097485) | 4.43 | 2 | LAMB2, PTPRO |
response to organic substance (GO:0010033) | 2.2 | 2 | WT1, ARHGDIA |
regulation of phosphorylation (GO:0042325) | 2.5 | 2 | EMP2, PLCE1 |
positive regulation of phosphorylation (GO:0042327) | 2.9 | 2 | PLCE1, EMP2 |
single organism reproductive process (GO:0044702) | 2.73 | 2 | WT1, EMP2 |
single-multicellular organism process (GO:0044707) | 1.78 | 2 | WT1, NPHS1 |
cell motility (GO:0048870) | 3.02 | 2 | EMP2, PTPRO |
positive regulation of organelle organization (GO:0010638) | 3.38 | 2 | NPHS1, OPA1 |
immune system process (GO:0002376) | 2.29 | 2 | EMP2, PTPRO |
cellular response to stress (GO:0033554) | 2.51 | 2 | NPHS1, OPA1 |
organophosphate metabolic process (GO:0019637) | 3.04 | 2 | DGKE, PLCE1 |
regulation of cell morphogenesis (GO:0022604) | 3.4 | 2 | ARHGDIA, PTPRO |
glomerular epithelial cell differentiation (GO:0072311) | 7.78 | 2 | WT1, PTPRO |
positive regulation of kinase activity (GO:0033674) | 3.54 | 2 | PLCE1, EMP2 |
protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205) | 6.26 | 2 | DGKE, PLCE1 |
cell differentiation involved in kidney development (GO:0061005) | 6.64 | 2 | WT1, PTPRO |
regulation of vasculature development (GO:1901342) | 4.26 | 2 | WT1, EMP2 |
regulation of cell migration (GO:0030334) | 3.23 | 2 | ARHGDIA, EMP2 |
actin filament-based process (GO:0030029) | 3.94 | 2 | NPHS2, EMP2 |
cell morphogenesis involved in differentiation (GO:0000904) | 4.67 | 2 | WT1, LAMB2 |
positive regulation of transferase activity (GO:0051347) | 3.31 | 2 | EMP2, PLCE1 |
positive regulation of GTPase activity (GO:0043547) | 3.28 | 2 | ARHGDIA, PLCE1 |
positive regulation of hydrolase activity (GO:0051345) | 2.91 | 2 | ARHGDIA, PLCE1 |
intracellular protein transport (GO:0006886) | 3.2 | 2 | NUP93, NUP107 |
regulation of kinase activity (GO:0043549) | 3.07 | 2 | PLCE1, EMP2 |
metanephric glomerular visceral epithelial cell development (GO:0072249) | 9.04 | 2 | NPHS2, LAMB2 |
regulation of cell-substrate adhesion (GO:0010810) | 4.56 | 2 | EMP2, PTPRO |
renal filtration cell differentiation (GO:0061318) | 7.78 | 2 | WT1, PTPRO |
epithelial cell differentiation involved in kidney development (GO:0035850) | 7.43 | 2 | WT1, PTPRO |
cell migration (GO:0016477) | 3.12 | 2 | EMP2, PTPRO |
G-protein coupled receptor signaling pathway (GO:0007186) | 2.64 | 2 | DGKE, PLCE1 |
anatomical structure formation involved in morphogenesis (GO:0048646) | 3.01 | 2 | WT1, NPHS1 |
lipid metabolic process (GO:0006629) | 2.68 | 2 | DGKE, PLCE1 |
regulation of biosynthetic process (GO:0009889) | 1.37 | 2 | WT1, NUP107 |
tissue development (GO:0009888) | 3.27 | 2 | WT1, NPHS1 |
sensory perception of light stimulus (GO:0050953) | 4.4 | 2 | LAMB2, OPA1 |
negative regulation of cell morphogenesis involved in differentiation (GO:0010771) | 4.96 | 2 | ARHGDIA, PTPRO |
response to stress (GO:0006950) | 1.8 | 2 | NPHS1, OPA1 |
glomerular visceral epithelial cell differentiation (GO:0072112) | 7.78 | 2 | WT1, PTPRO |
regulation of actin cytoskeleton organization (GO:0032956) | 4.09 | 2 | ARHGDIA, NPHS1 |
regulation of hydrolase activity (GO:0051336) | 2.53 | 2 | ARHGDIA, PLCE1 |
excretion (GO:0007588) | 6.04 | 2 | NPHS2, NPHS1 |
positive regulation of protein modification process (GO:0031401) | 2.7 | 2 | EMP2, PLCE1 |
regulation of transferase activity (GO:0051338) | 2.88 | 2 | EMP2, PLCE1 |
positive regulation of nervous system development (GO:0051962) | 3.64 | 2 | ARHGDIA, OPA1 |
negative regulation of nervous system development (GO:0051961) | 4.15 | 2 | ARHGDIA, PTPRO |
regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 2 | WT1, NUP107 |
regulation of cell motility (GO:2000145) | 3.16 | 2 | ARHGDIA, EMP2 |
regulation of response to external stimulus (GO:0032101) | 3.06 | 2 | NUP93, PTPRO |
phosphorylation (GO:0016310) | 2.63 | 2 | NPHS1, DGKE |
protein import (GO:0017038) | 4.85 | 2 | NUP93, NUP107 |
cell differentiation (GO:0030154) | 2.14 | 2 | WT1, PTPRO |
regulation of Ras protein signal transduction (GO:0046578) | 4.49 | 2 | ARHGDIA, PLCE1 |
regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 2 | WT1, NUP107 |
positive regulation of signaling (GO:0023056) | 2.41 | 2 | EMP2, PLCE1 |
negative regulation of signaling (GO:0023057) | 2.65 | 2 | OPA1, PTPRO |
metanephric glomerular epithelial cell development (GO:0072313) | 9.04 | 2 | NPHS2, LAMB2 |
negative regulation of cell communication (GO:0010648) | 2.66 | 2 | OPA1, PTPRO |
cellular response to chemical stimulus (GO:0070887) | 2.57 | 2 | WT1, ARHGDIA |
muscle structure development (GO:0061061) | 4.96 | 2 | WT1, NPHS1 |
axon guidance (GO:0007411) | 4.44 | 2 | LAMB2, PTPRO |
positive regulation of cell communication (GO:0010647) | 2.41 | 2 | EMP2, PLCE1 |
regulation of GTPase activity (GO:0043087) | 3.21 | 2 | ARHGDIA, PLCE1 |
response to organic cyclic compound (GO:0014070) | 3.07 | 2 | WT1, ARHGDIA |
positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 2 | PLCE1, EMP2 |
positive regulation of protein metabolic process (GO:0051247) | 2.43 | 2 | PLCE1, EMP2 |
negative regulation of neurogenesis (GO:0050768) | 4.22 | 2 | ARHGDIA, PTPRO |
positive regulation of neurogenesis (GO:0050769) | 3.77 | 2 | ARHGDIA, OPA1 |
regulation of cell morphogenesis involved in differentiation (GO:0010769) | 3.91 | 2 | ARHGDIA, PTPRO |
positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 2 | PLCE1, EMP2 |
regulation of protein modification process (GO:0031399) | 2.32 | 2 | EMP2, PLCE1 |
phospholipid metabolic process (GO:0006644) | 3.88 | 2 | DGKE, PLCE1 |
cell proliferation (GO:0008283) | 3.23 | 2 | PLCE1, EMP2 |
establishment of protein localization to organelle (GO:0072594) | 3.92 | 2 | NUP93, NUP107 |
negative regulation of cell development (GO:0010721) | 4.02 | 2 | ARHGDIA, PTPRO |
negative regulation of locomotion (GO:0040013) | 4.22 | 2 | ARHGDIA, PTPRO |
regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 2 | WT1, NUP107 |
positive regulation of cell differentiation (GO:0045597) | 3.01 | 2 | ARHGDIA, OPA1 |
negative regulation of cell differentiation (GO:0045596) | 3.33 | 2 | ARHGDIA, PTPRO |
regulation of cell growth (GO:0001558) | 3.75 | 2 | WT1, PLCE1 |
cellular lipid metabolic process (GO:0044255) | 2.92 | 2 | DGKE, PLCE1 |
negative regulation of axonogenesis (GO:0050771) | 5.52 | 2 | ARHGDIA, PTPRO |
regulation of axonogenesis (GO:0050770) | 4.59 | 2 | ARHGDIA, PTPRO |
cellular response to organic cyclic compound (GO:0071407) | 3.93 | 2 | WT1, ARHGDIA |
regulation of RNA metabolic process (GO:0051252) | 1.52 | 2 | WT1, NUP107 |
protein localization to organelle (GO:0033365) | 3.57 | 2 | NUP93, NUP107 |
positive regulation of protein kinase activity (GO:0045860) | 3.61 | 2 | PLCE1, EMP2 |
protein localization to nucleus (GO:0034504) | 4.9 | 2 | NUP93, NUP107 |
cell projection assembly (GO:0030031) | 4.19 | 2 | EMP2, PTPRO |
cell death (GO:0008219) | 3.05 | 2 | OPA1, EMP2 |
regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 2 | WT1, NUP107 |
regulation of growth (GO:0040008) | 3.26 | 2 | WT1, PLCE1 |
single-organism nuclear import (GO:1902593) | 5.24 | 2 | NUP93, NUP107 |
regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 2 | WT1, NUP107 |
renal system process involved in regulation of blood volume (GO:0001977) | 6.96 | 2 | EMP2, PTPRO |
regulation of renal system process (GO:0098801) | 6.12 | 2 | EMP2, PTPRO |
cellular response to organic substance (GO:0071310) | 2.78 | 2 | WT1, ARHGDIA |
neurological system process (GO:0050877) | 2.64 | 2 | LAMB2, OPA1 |
regulation of actin filament-based process (GO:0032970) | 3.97 | 2 | ARHGDIA, NPHS1 |
positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 2 | EMP2, PLCE1 |
regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 2 | WT1, NUP107 |
protein import into nucleus (GO:0006606) | 5.24 | 2 | NUP93, NUP107 |
regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 2 | EMP2, PLCE1 |
reproductive process (GO:0022414) | 2.55 | 2 | WT1, EMP2 |
renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 6.68 | 2 | EMP2, PTPRO |
nuclear import (GO:0051170) | 5.06 | 2 | NUP93, NUP107 |
regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 2 | WT1, NUP107 |
response to chemical (GO:0042221) | 1.98 | 2 | WT1, ARHGDIA |
Ras protein signal transduction (GO:0007265) | 4.76 | 2 | ARHGDIA, PLCE1 |
small GTPase mediated signal transduction (GO:0007264) | 3.85 | 2 | ARHGDIA, PLCE1 |
lipid biosynthetic process (GO:0008610) | 3.49 | 2 | DGKE, PLCE1 |
locomotion (GO:0040011) | 2.91 | 2 | EMP2, PTPRO |
heart development (GO:0007507) | 4.24 | 2 | WT1, PLCE1 |
negative regulation of cellular component movement (GO:0051271) | 4.22 | 2 | ARHGDIA, PTPRO |
cytoskeleton organization (GO:0007010) | 3.22 | 2 | NPHS2, PLCE1 |
regulation of protein phosphorylation (GO:0001932) | 2.57 | 2 | PLCE1, EMP2 |
positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 2 | PLCE1, EMP2 |